Patient Selection Key to DKA Prevention With SGLT Inhibitors in Type 1 Diabetes Patient Selection Key to DKA Prevention With SGLT Inhibitors in Type 1 Diabetes

Selection of appropriate patients for sodium-glucose cotransporter (SGLT)-inhibitor therapy is"critical" to minimizing the risk of diabetic ketoacidosis (DKA), an expert panel advises in a new consensus report.Reuters Health Information
Source: Medscape Pathology Headlines - Category: Pathology Tags: Diabetes & Endocrinology News Source Type: news